Loading clinical trials...

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNEARLY Phase 1NCT03973125

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma

The aim of this study was to investigate the safety and effectiveness of application of intravitreal conbercept injection as the primary treatment for exudative circumscribed choroidal haemangioma.

Lead sponsor: Sun Yat-sen University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Kunbei Lai

CONTACT

8602087331366 laikb@163.com

Chenjin Jin, Ph.D.

CONTACT

Study Principal Investigator jinchj@126.com

Related studies

UNKNOWNEARLY Phase 1

Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma

NCT03571282 · Circumscribed Choroidal Haemangioma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 4, 2019Terms

Trial snapshot

StatusUNKNOWN

PhaseEARLY_PHASE1

Enrollment50

Start dateAug 2014

Last updatedJun 4, 2019

Condition

Circumscribed Choroidal Haemangioma

Locations shown

Kunbei Lai

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 4, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions